|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
3
|
Fu Z, Deng H, Wang X, Yang X, Wang Z and
Liu L: Involvement of ER-alpha36 in the malignant growth of gastric
carcinoma cells is associated with GRP94 overexpression.
Histopathology. 63:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sipponen P and Correa P: Delayed rise in
incidence of gastric cancer in females results in unique sex ratio
(M/F) pattern: etiologic hypothesis. Gastric Cancer. 5:213–219.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chandanos E and Lagergren J: Oestrogen and
the enigmatic male predominance of gastric cancer. Eur J Cancer.
44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
7
|
Parkin DM, Pisani P and Ferlay J: Global
cancer statistics. CA Cancer J Clin. 49:33–64. 1999. View Article : Google Scholar
|
|
8
|
Furukawa H, Iwanaga T, Koyama H and
Taniguchi H: Effect of sex hormones on carcinogenesis in the
stomachs of rats. Cancer Res. 42:5181–5182. 1982.PubMed/NCBI
|
|
9
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: A variant of estrogen receptor-{alpha},
hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent
membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA.
103:9063–9068. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Wang L, Han R, et al:
Identification of the forkhead transcriptional factor 2 (FOXL2)
gene mutations in four Chinese families with blepharophimosis
syndrome. Mol Vis. 19:2298–2305. 2013.PubMed/NCBI
|
|
11
|
Deng H, Huang X, Fan J, et al: A variant
of estrogen receptor-alpha, ER-alpha36 is expressed in human
gastric cancer and is highly correlated with lymph node metastasis.
Oncol Rep. 24:171–176. 2010.PubMed/NCBI
|
|
12
|
D’Angelo A, Bluteau O, Garcia-Gonzalez MA,
et al: Hepatocyte nuclear factor 1alpha and beta control terminal
differentiation and cell fate commitment in the gut epithelium.
Development. 137:1573–1582. 2010.PubMed/NCBI
|
|
13
|
Yuasa Y: Control of gut differentiation
and intestinal-type gastric carcinogenesis. Nat Rev Cancer.
3:592–600. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilkinson NW, Howe J, Gay G, Patel-Parekh
L, Scott-Conner C and Donohue J: Differences in the pattern of
presentation and treatment of proximal and distal gastric cancer:
results of the 2001 gastric patient care evaluation. Ann Surg
Oncol. 15:1644–1650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Sakamoto K and Wagner KU: D-type
cyclins are important downstream effectors of cytokine signaling
that regulate the proliferation of normal and neoplastic mammary
epithelial cells. Mol Cell Endocrinol. 382:583–592. 2014.
View Article : Google Scholar
|
|
16
|
Glassford J, Rabin N, Lam EW and Yong KL:
Functional regulation of D-type cyclins by insulin-like growth
factor-I and serum in multiple myeloma cells. Br J Haematol.
139:243–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sherr CJ: D-type cyclins. Trends Biochem
Sci. 20:187–190. 1995. View Article : Google Scholar
|
|
18
|
Sauter ER, Yeo UC, von Stemm A, et al:
Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer
Res. 62:3200–3206. 2002.PubMed/NCBI
|
|
19
|
Udhayakumar G, Jayanthi V, Devaraj N and
Devaraj H: Interaction of MUC1 with beta-catenin modulates the Wnt
target gene cyclinD1 in H. pylori-induced gastric cancer. Mol
Carcinog. 46:807–817. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arber N, Gammon MD, Hibshoosh H, et al:
Overexpression of Cyclin D1 occurs in both squamous carcinomas and
adenocarcinomas of the esophagus and in adenocarcinomas of the
stomach. Hum Pathol. 30:1087–1092. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bar-Sela G, Hershkovitz D, Haim N,
Kaidar-Person O, Shulman K and Ben-Izhak O: The incidence and
prognostic value of HER2 overexpression and cyclin D1 expression in
patients with gastric or gastroesophageal junction adenocarcinoma
in Israel. Oncol Lett. 5:559–563. 2013.PubMed/NCBI
|
|
22
|
Motohashi M, Wakui S, Muto T, et al:
Cyclin D1/cdk4, estrogen receptors alpha and beta, in
N-methyl-N′-nitro-N-nitrosoguanidine-induced rat gastric
carcinogenesis: immunohistochemical study. J Toxicol Sci.
36:373–378. 2011.PubMed/NCBI
|
